LFG
ONC

Larson Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Larson Financial Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
39
+19
+95% +$5.6K ﹤0.01% 2338
2026
Q1 		$5.94K Buy
20
+14
+233% +$4.53K ﹤0.01% 2515
2025
Q4 		$1.82K Hold
6
– – ﹤0.01% 2799
2025
Q3 		$2.04K Hold
6
– – ﹤0.01% 2702
2025
Q2 		$1.45K Hold
6
– – ﹤0.01% 2527
2025
Q1 		$1.63K Hold
6
– – ﹤0.01% 2229
2024
Q4 		$1.11K Hold
6
– – ﹤0.01% 2021
2024
Q3 		$1.35K Buy
+6
New +$1.08K ﹤0.01% 1924
2023
Q3 		– Sell
-23
Closed -$4.1K – 1768
2023
Q2 		$4.1K Hold
23
– – ﹤0.01% 1142
2023
Q1 		$4.96K Buy
+23
New +$5.52K ﹤0.01% 1090

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Larson Financial Group's ONC Position: Q2 2026 in Review

Larson Financial Group increased its BeOne Medicines Ltd (ONC) stake by 95% in Q2 2026, buying an estimated $5.6K and bringing the position to 39 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2338.

Larson Financial Group first reported a position in ONC in Q1 2023 and has held it in 10 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Larson Financial Group held 39 shares of BeOne Medicines Ltd worth $11.1K as of Q2 2026.
  • Larson Financial Group bought 19 BeOne Medicines Ltd shares in Q2 2026, an estimated $5.6K.
  • BeOne Medicines Ltd made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2338 holding.
  • Larson Financial Group first reported a position in BeOne Medicines Ltd in Q1 2023 and has held it in 10 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.